Replies to post #97686 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

I had always assumed the partial hold for AIM2CERV was due to the request for a second interim look. Reading the PR from 3/12, it appears the hold was due to other causes. If I'm interpreting this wrong, please let me know.

Has ADXS ever stated very clearly any issues that have a negative impact on the share price?

Good to be ready for some good news but be prepared for bad news. As a reminder, trace back the events leading to the EU submission and the long silence followed by the bad news of withdrawing the application - all of this after the delay in filing and hiring consultants to do it. Not a confidence builder(this management).

[ignatiusrielly35]

This was discussed months ago. Clearly the questions posed by the FDA were prompted by the request to modify the trial design, as evidenced by the timing.